Cardiovascular risk factor control in antiphospholipid syndrome, and differences between primary and systemic lupus erythematosus-related antiphospholipid syndrome (SURF-SLE and APS project): a cross-sectional study of 1003 individuals from 11 countries

By afschroeder • November 23, 2025

Bolla E, Semb AG, Petri M, Sfikakis PP, Artim-Esen B, Hernandez-Molina G, Hachulla E, Direskeneli H, Karpouzas GA, Zucchi D, Goyal M, Costedoat-Chalumeau N, Tincani A, Yazici A, Lerang K, Troldborg A, Ajeganova S, Popkova TV, Svenungsson E, Pantazis N, Tektonidou MG; SURF-SLE and APS collaborators. Cardiovascular risk factor control in antiphospholipid syndrome, and differences between primary and systemic lupus erythematosus-related antiphospholipid syndrome (SURF-SLE and APS project): a cross-sectional study of 1003 individuals from 11 countries. Lancet Rheumatol. 2025 Nov 19:S2665-9913(25)00257-7. doi: 10.1016/S2665-9913(25)00257-7. Epub ahead of print. PMID: 41274305.

Tags: Harbor UCLA, Publications, Rheumatology

Interleukin-6 Inhibition with Ziltivekimab for Atherosclerotic Disease

Ridker PM, Lincoff AM, Marx N, Navar AM, Sattar N, Tuttle KR, Budoff M, Böttcher M, Cavender MA, Choudhury RP, Cornel JH, Gajos G, Komuro[...]

Development and Validation of a Pre-COPD Score to Predict Incident COPD

Çolak Y, Bhatt SP, Kinney GL, Casaburi R, Nordestgaard BG, Vestbo J, Lange P, Afzal S. Development and Validation of a Pre-COPD Score to Predict[...]

Advancements in Artificial Intelligence for Enhanced Diagnosis and Prognosis in Cardiac CT: a Comprehensive Review and Future Perspectives

Adabifirouzjaei F, Budoff M, Nomeli M. Advancements in Artificial Intelligence for Enhanced Diagnosis and Prognosis in Cardiac CT: a Comprehensive Review and Future Perspectives. Curr[...]